Production Process for Stem Cell Based Therapeutic Implants: Expansion of the Production Cell Line and Cultivation of Encapsulated Cells
Cell based therapy promises the treatment of many diseases like diabetes mellitus, Parkinson disease or stroke. Microencapsulation of the cells protects them against host-vs-graft reactions and thus enables the usage of allogenic cell lines for the manufacturing of cell therapeutic implants. The production process of such implants consists mainly of the three steps expansion of the cells, encapsulation of the cells, and cultivation of the encapsulated cells in order to increase their vitality and thus quality. This chapter deals with the development of fixed-bed bioreactor-based cultivation procedures used in the first and third step of production. The bioreactor system for the expansion of the stem cell line (hMSC-TERT) is based on non-porous glass spheres, which support cell growth and harvesting with high yield and vitality. The cultivation process for the spherical cell based implants leads to an increase of vitality and additionally enables the application of a medium-based differentiation protocol.
KeywordsCell therapy Mesenchymal stem cells Encapsulation Fixed bed bioreactor Glass carrier
The authors would like to thank the Federal Ministry of Economics and Technology for financial support as well as the CellMed AG for providing the production cell line hMSC-TERT and the CellBeads®.
- 2.Freimark D, Czermak P (2009) Cell-based regeneration of intervertebral disc defects: review and concepts. Int J Artif Organs 32:197–203Google Scholar
- 8.Heile AMB et al (2009) Cerebral Q1 transplantation of encapsulated mesenchymal stem cells improves cellular pathology after experimental traumatic brain injury. Neurosci LettGoogle Scholar
- 9.Aris R (1975) The mathematical theory of diffusion and reaction impermeable catalysts. Clarendon, OxfordGoogle Scholar
- 10.Bailey J, Ollis DF (1986) Biochemical engineering fundamentals. McGraw-Hill, New YorkGoogle Scholar
- 11.Froment GF, Bischoff KB (1979) Chemical reactor analysis and design. Wiley, New YorkGoogle Scholar
- 12.Fassnacht D (2001) Fixed-bed reactors for the cultivation of animal cells. Fortschritt-Berichte VDI, vol. 17, VDI-Verlag, DüsseldorfGoogle Scholar
- 13.Willaert RG, Baron GV, de Backer L (1996) Modelling of immobilised bioprocesses. In: Willaert RG, Baron GV, de Backer L (eds) Immobilised living cell systems. Wiley, New York, pp 237–254Google Scholar
- 14.Perry RH, Green DW (2007) Perry’s chemical engineers’ handbook. McGraw-HillGoogle Scholar
- 15.Weber C, Gokorsch S, Czermak P (2007) Expansion and chondrogenic differentiation of human mesenchymal stem cells. Int J Artif Organs 30:611–618Google Scholar
- 21.Guo Z et al (2001) Biological features of mesenchymal stem cells from human bone marrow. Chin Med J 114:950–953Google Scholar
- 22.Soukup T et al (2006) Mesenchymal stem cells isolated from human bone marrow: cultivation, phenotypic analysis and changes in proliferation kinetics. Acta Med 49:27–33Google Scholar
- 28.Weber C et al (2007) Cultivation and differentiation of encapsulated hMSC-TERT in a disposable small-scale syringe-like fixed bed reactor. Open Biomed Eng J 1:64–70Google Scholar